Keratinocyte differentiation pathways and stratum corneum cohesion proteins

Keratinocyte differentiation pathways and stratum corneum cohesion proteins represent the integrated biological processes and structural elements required to maintain the skin's protective barrier. This complex system involves the terminal differentiation of keratinocytes into corneocytes, a process driven by the sequential expression of proteins within the Epidermal Differentiation Complex (EDC), such as Filaggrin, Loricrin, and Involucrin (StatPearls, NBK470465). These proteins are enzymatically cross-linked by transglutaminases to form the cornified envelope, while cohesion between these cells is mediated by specialized junctions called corneodesmosomes (PubMed, PMC3033343). Defects in these pathways or the underlying proteins are central to the pathogenesis of inflammatory skin diseases like atopic dermatitis and psoriasis, as well as genetic disorders like ichthyosis (PubMed, PMC3507337). Pharmacological intervention typically involves the use of retinoids or vitamin D analogs that bind to nuclear receptors to normalize differentiation gene expression, or anti-inflammatory agents that prevent the downregulation of barrier proteins by Th2 cytokines (PubMed, PMC7139064). Consequently, these pathways are critical focal points for both topical and systemic dermatological therapies aimed at restoring skin integrity and function.

Other names

Epidermal differentiation complex (EDC)Skin barrier proteinsCornified envelope proteinsKeratinization pathway

Modulation of gene transcription via nuclear receptor activation (RAR, VDR) and inhibition of cytokine-mediated suppression of barrier protein synthesis (PubMed, PMC7139064).